JUSTIN KUCINSKI
Allopathic & Osteopathic Physicians|Internal Medicine SALISBURY, MD NPI 1689000697
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine MD Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$6,333.71
- Category: General Payments
- Program years: PY2018–2024
- Record count: 279
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,092.87 across 48 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,092.87 | 48 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $177.58 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $139.12 | 10 |
| GlaxoSmithKline, LLC. | $102.38 | 4 |
| PFIZER INC. | $90.41 | 4 |
| Genentech USA, Inc. | $71.86 | 4 |
| Daiichi Sankyo Inc. | $60.84 | 3 |
| Acerta Pharma LLC | $51.34 | 2 |
| Mirati Therapeutics, Inc. | $48.18 | 2 |
| Regeneron Healthcare Solutions, Inc. | $39.42 | 2 |
| ABBVIE INC. | $36.50 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.82 | 1 |
| Lilly USA, LLC | $29.31 | 1 |
| Immunocore Limited | $28.58 | 1 |
| PharmaEssentia USA Corporation | $25.80 | 1 |
| Merck Sharp & Dohme Corporation | $25.44 | 1 |
| GENZYME CORPORATION | $23.27 | 1 |
| Celgene Corporation | $22.50 | 1 |
| Kyowa Kirin, Inc. | $19.61 | 1 |
| SECURA BIO, INC. | $19.30 | 1 |
| ADC Therapeutics America, Inc. | $17.96 | 1 |
| Gilead Sciences, Inc. | $14.45 | 1 |
| ARRAY BIOPHARMA INC | $14.20 | 1 |
By program year
Records — PY2024 (48)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.